A case of Posterior Reversible Encephalopathy Syndrome (PRES) associated with Gilenya® (Fingolimod) treatment for Multiple Sclerosis (MS).
We describe Posterior Reversible Encephalopathy Syndrome (PRES) in a woman with Multiple Sclerosis (MS) treated with Gilenya® (Fingolimod). The first symptoms appeared after 21 months of fingolimod treatment. She experienced headache, altered mental status, cognitive deficits, seizures and visual di...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2015-03-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00039/full |